Attenuated vif DNA immunization cassettes for genetic vaccines
US8183352B2 · kind B2 · utility
54Cited by
4References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2006 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Feb 4, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to nucleic acid molecules encoding attenuated, non-functional virion infectivity factor (vif) proteins. The nucleic acid molecules of the invention are inserted into recombinant expression vectors and administered to mammals in order to induce a cellular and humoral immune response to the encoded protein product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.